Kadouri A, Bohak Z
Dev Biol Stand. 1985;60:431-7.
Plasminogen activator (PA) is a serine protease with a proven medical application as a fibrinolytic drug. PA is a normal constituent of animal tissues and is found in low concentration 1-10 U/ml in the supernatant of various cells in culture. We found that certain strains of untransformed human diploid fibroblasts can be adapted to produce PA at levels of 100 U/ml or more by culture with specific combinations of serum and coated substrates. Once the cells are adapted, they continue to produce the enzyme in a medium devoid of serum in which cell proliferation is minimal. The time course of enzyme production revealed that its formation is controlled by negative feedback and stops when its level in the medium reaches a critical concentration. However on removal of the enzyme by continuously replacing the medium, the cells continue to produce enzyme at a constant rate for a period of several weeks. Possible biotechnological configurations for large scale production of this enzyme are now under study. The PA purified from the spent medium of these cells was identified as tissue type activator similar to the melanoma type PA.
纤溶酶原激活剂(PA)是一种丝氨酸蛋白酶,作为一种纤维蛋白溶解药物已在医学上得到证实。PA是动物组织的正常成分,在培养的各种细胞的上清液中以1 - 10 U/ml的低浓度存在。我们发现,某些未转化的人二倍体成纤维细胞系可通过与特定组合的血清和包被底物一起培养,适应产生100 U/ml或更高水平的PA。一旦细胞适应,它们会在无血清的培养基中继续产生这种酶,而在这种培养基中细胞增殖极少。酶产生的时间进程表明,其形成受负反馈控制,当培养基中的水平达到临界浓度时停止。然而,通过持续更换培养基去除酶后,细胞会在数周时间内以恒定速率继续产生酶。目前正在研究大规模生产这种酶的可能生物技术配置。从这些细胞的用过的培养基中纯化的PA被鉴定为与黑色素瘤型PA相似的组织型激活剂。